The global arterial cannula market size was valued at USD 23.80 million in 2025 and is projected to grow from USD 25.61 billion in 2026 to USD 46.01 billion by 2034, registering a CAGR of 7.60% during the forecast period (2026-2034). North America dominated the arterial cannula market with a share of 42.10% in 2025.
Arterial cannulas are sterile medical devices used to access arteries for continuous blood pressure monitoring and repeated arterial blood sampling. These devices are commonly used in intensive care units, operating rooms, and emergency departments. They are classified under HSN Code 90183930 (Cannulae) and SIC Code 3841 (Surgical and Medical Instruments and Apparatus).
The arterial cannula market demand is driven by the increasing number of critical care admissions, rising cardiovascular surgical procedures, and growing use of invasive blood pressure monitoring. The adoption of safety-engineered cannulas and improved catheter materials supports arterial cannula market growth.
Download a Free Sample To learn more about this report,
Adoption of Integrated Arterial Cannulation Systems
The arterial cannula market analysis indicates a growing preference for integrated arterial cannulation systems that simplify catheter placement and improve procedural safety. Hospitals are focusing on devices with built-in guidewires, blood flashback indicators, and needle protection features. These designs support faster arterial access and reduce handling during insertion. For instance, Teleflex offers the Arrow QuickFlash Arterial Catheter, which provides rapid visual confirmation of arterial blood return.
Shift Toward Closed Arterial Blood Sampling Systems
Adoption of closed arterial blood sampling systems is influencing arterial cannula selection in intensive care settings. These systems allow repeated blood collection while reducing blood wastage and unnecessary exposure during sampling. Hospitals are increasingly considering compatibility between arterial cannulas, pressure transducers, and closed sampling devices.
Supply chain disruptions are expected to have a moderate impact on the arterial cannula market share due to shortages of medical-grade polymers, stainless steel needles, and sterilization services. The market is expected to experience a K-shaped recovery, as established manufacturers can maintain production through diversified suppliers. Smaller manufacturers may face longer procurement delays and higher production costs. The market is projected to grow at a CAGR of 7.60%, but supply constraints could temporarily reduce growth by approximately 1.5 percentage points to 6.10%. Improved raw material availability, stable sterilization capacity, and shorter delivery times are expected to restore market growth toward 7.60%.
The arterial cannula market forecasts investment activity focused on vascular access technology, catheter manufacturing capacity, and medical device production.
Key Investment and Funding Activities in Arterial Cannula Market, 2025–2026
Demand for Arterial Cannulation in Vasopressor Therapy Receivers and Adoption of Invasive Arterial Monitoring Drives Market
Vasopressor therapy use in critically ill patients is supporting demand for arterial cannulas. These medications require close blood pressure monitoring to maintain adequate organ perfusion. Arterial cannulation provides continuous pressure readings and supports precise medication adjustments. The Surviving Sepsis Campaign guidelines recommend an initial mean arterial pressure target of 65 mmHg for adults with septic shock receiving vasopressors. This requirement supports arterial cannula utilization in intensive care settings.
Complex surgical procedures often involve rapid changes in blood pressure due to blood loss and anesthesia-related complications. Intermittent blood pressure measurements may not detect these changes immediately, increasing the need for continuous arterial monitoring. Their application in cardiac surgery and major vascular procedures is contributing to arterial cannula market growth.
Risk of Catheter-Related Complications and Shortage of Skilled Healthcare Professionals Restrain Market Expansion
Arterial cannulation carries risks of catheter blockage, thrombosis, and bloodstream infection. These complications may require catheter removal and additional clinical intervention. Prolonged catheter placement can increase the risk of vascular injury and local infection, particularly in critically ill patients. Such risks increase clinical monitoring requirements and treatment costs.
Arterial cannulation requires trained healthcare professionals to ensure accurate catheter placement and minimize procedural complications. The procedure requires specialized skills, especially when accessing arteries with weak or hard-to-detect pulses. Limited availability of trained personnel restricts arterial cannula utilization in smaller hospitals and healthcare facilities.
Ultrasound-Guided Dynamic Needle-Tip Positioning Technology and Development of Longer-Lasting Arterial Cannulas with Improved Fixation Offers Growth Opportunities
Advancements in ultrasound-guided dynamic needle-tip positioning technology are creating opportunities for arterial cannula manufacturers. This technology enables continuous visualization of the needle tip during arterial insertion, improving placement accuracy and reducing unsuccessful attempts. T
The growing focus on improving catheter stability and durability is creating opportunities for manufacturers to develop arterial cannulas with enhanced fixation systems and kink-resistant materials. Accidental dislodgement and catheter occlusion can interrupt continuous blood pressure monitoring. Improved catheter stability may reduce unnecessary replacement procedures and preserve arterial access during prolonged intensive care.
Cardiopulmonary bypass surgery dominated the application segment in 2025, accounting for a share of 62.50%. This growth is attributed to high utilization of arterial cannulas during open-heart surgeries. The increasing volume of cardiac valve replacement and coronary bypass procedures supports segment dominance.
Extracorporeal membrane oxygenation will expand to 9.20% CAGR during the forecast period, owing to increasing demand for temporary circulatory support in patients with severe cardiac failure. The expanding use of venoarterial ECMO supports segment growth.
Request Customizationto receive a tailored report.
In 2025, 20–22 Fr had a share of 23.50%, driven by its suitability for arterial blood return during adult cardiopulmonary bypass procedures. The established use of these cannula sizes in cardiac surgery supports segment dominance.
14–16 Fr is anticipated to record a growth rate of 9.50% during the forecast period, propelled by increasing demand for smaller arterial cannulas in selected pediatric procedures. The need for appropriate vessel compatibility supports segment growth.
Hospitals led the end user segment with a share of 83.50% in 2025, owing to the high concentration of cardiac surgeries requiring extracorporeal circulation. The availability of specialized cardiac operating rooms supports consistent arterial cannula utilization.
Ambulatory surgical centers are expected to achieve a growth rate of 8.20%, due to rising demand for outpatient procedures requiring invasive arterial monitoring. The expansion of specialized outpatient surgical services supports arterial cannula adoption in selected procedures.
Speak to an Analystto discuss market opportunities.
The North America arterial cannula market accounted for the largest regional share of 42.10% in 2025.
U.S. has an established cardiac surgery infrastructure that supports demand for arterial cannulas used in cardiopulmonary bypass procedures. The use of minimally invasive cardiac surgery is increasing the need for peripheral arterial cannulation techniques. These procedures often require femoral arterial access to maintain extracorporeal circulation without conventional central aortic cannulation.
Canada's centralized cardiac care services support arterial cannula demand across designated surgical hospitals. The Canadian Institute for Health Information monitors coronary artery bypass grafting as a major cardiac revascularization procedure. Provincial healthcare systems rely on specialized cardiac centers for these operations. The concentration of cardiac surgical services supports regular procurement of arterial cannulas and encourages standardized device selection across hospital networks.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific arterial cannula market is expected to grow at a CAGR of 8.90% during the forecast period, showcasing the fastest-growing regional market.
Volume-based procurement is reshaping the purchasing of medical consumables in China's public healthcare sector. Government efforts to control medical expenditure are encouraging hospitals to prioritize competitively priced devices. Domestic manufacturers have opportunities to strengthen their presence by supplying arterial cannulas that meet hospital quality requirements.
India's Ayushman Bharat Pradhan Mantri Jan Arogya Yojana covers several cardiothoracic procedures, including aortic valve surgery and congenital heart defect repair. These procedures may require arterial cannulation for cardiopulmonary bypass. The availability of cashless treatment packages helps eligible patients access specialized cardiac care.
Geriatric population in Japan is influencing demand for arterial cannulas used in complex cardiovascular surgery. Age-related cardiovascular conditions increase the need for surgical interventions involving cardiopulmonary bypass. Elderly patients undergoing aortic repair may require careful selection of arterial cannulation sites due to vascular calcification and reduced vessel flexibility.
Europe's arterial cannula market will expand at a CAGR of 6.80% during the forecast period.
NICE guidance supports the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for severe acute heart failure as a bridge to recovery or heart transplantation. This treatment requires arterial cannulation to return oxygenated blood into the patient's circulation. The recognition of VA-ECMO in specialized cardiac care creates opportunities for arterial cannula manufacturers. Demand for reliable large-bore cannulas is expected to strengthen across eligible NHS cardiac centers.
Adoption of minimally invasive mitral valve surgery is influencing arterial cannula demand in Germany. These procedures often use femoral arterial cannulation to establish cardiopulmonary bypass through smaller surgical incisions. The German Society for Thoracic and Cardiovascular Surgery tracks minimally invasive cardiac procedures through its national registry.
Latin America's arterial cannula market is expected to experience a growth rate of 7.50% during the forecast period. In Brazil Unified Health System (SUS) provides specialized cardiovascular treatment through accredited hospitals, supporting arterial cannula consumption during cardiopulmonary bypass procedures. Mexico's pediatric cardiac care services create additional demand for smaller arterial cannulas used in congenital heart defect correction.
The Middle East & Africa arterial cannula market is likely to witness a CAGR of 7.90% during the forecast period. The UAE's Dubai Health Authority provides cardiothoracic surgery services, including extracorporeal membrane oxygenation (ECMO) for patients with severe cardiac failure. These services support demand for large-bore arterial cannulas used in circulatory support.
South Africa's National Department of Health recognizes rheumatic heart disease as a cause of valvular damage. Patients requiring surgical valve replacement contribute to arterial cannula utilization during cardiopulmonary bypass procedures.
The arterial cannula market competitive landscape is moderately consolidated, comprising established cardiovascular device manufacturers and specialized regional cannula suppliers. Key players such as Medtronic, LivaNova, Getinge, Andocor, and BD are estimated to collectively account for approximately 45% of the global arterial cannula market share.
Established manufacturers compete through advanced cannula designs, established hospital procurement relationships, and strong distribution networks. Regional manufacturers in the arterial cannula market ecosystem emphasize competitive pricing, customized cannula sizes, and localized distribution.
July 2026: Total Flow Medical received U.S. FDA 510(k) clearance for its Femoral Arterial (TFA) Cannula.
April 2026: Medtronic received U.S. FDA 510(k) clearance for its Elongated One-Piece Arterial (EOPA) 3D Arterial Cannulae, designed for arterial perfusion.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Adult Pediatric Hemoconcentrators Market Size, Opportunities, 2034
Handheld Backscatter X-Ray Devices Market Size, Share, Growth, 2034
Ultrasound Devices Market Size, Share, Growth, Analysis, 2034
Catheter Directed Thrombolysis Market Size, Forecast, Demand, Opportunities, 2034
Breast Biopsy Device Market Size, Forecast, Opportunities, 2034
Antimicrobial Hospital Textile Market Size, Forecast, Opportunities, 2034
We are featured on:
sales@straitsresearch.com